RESUMEN
Polymer hydrogels formed by rapid thiol-ene coupling of macromolecular gel formers can offer access to versatile new matrices. This paper describes the efficient synthesis of cysteamine vinyl sulfone (CVS) trifluoroacetate, and its incorporation into poly(methyl vinyl ether-alt-maleic anhydride) (PMMAn) to form a series of CVS-functionalized poly(methyl vinyl ether-alt-maleic acid) polymers (PMM-CVSx) containing 10 to 30 mol% pendant vinyl sulfone groups. Aqueous mixtures of these PMM-CVS and a dithiol crosslinker, α,ω-dithio-polyethyleneglycol (HS-PEG-SH, Mn = 1 kDa), gelled through crosslinking by Michael addition within seconds to minutes, depending on pH, degree of functionalization, and polymer loading. Gelation efficiency, Young's modulus, equilibrium swelling and hydrolytic stability are described, and step-wise hydrogel post-functionalization with a small molecule thiol, cysteamine, was demonstrated. Cytocompatibility of these crosslinked hydrogels towards entrapped 3T3 fibroblasts was confirmed using a live/dead fluorescence assay.
Asunto(s)
Plexo Braquial/efectos de los fármacos , Vértebras Cervicales/patología , Bloqueo Nervioso/métodos , Nervio Radial/efectos de los fármacos , Nervio Radial/lesiones , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Nervio Radial/patología , Nervio Radial/cirugíaRESUMEN
Abrogation of telomere stability through loss-of-function mutations in telomere binding proteins contributes to genomic instability and cancer progression. Recently, Flap endonuclease 1 (FEN1) was shown to contribute to telomere stability in human cells that had not yet activated a telomere maintenance mechanism, suggesting that abrogation of FEN1 function influences the transformation process by compromising telomere stability and driving genomic instability. Here, we analyse the telomeres in human cancer cells following FEN1 depletion. We show that FEN1 is required for telomere stability in cells that rely on the alternative lengthening of telomere (ALT) mechanism. Indeed, FEN1 depletion resulted in telomere dysfunction, characterized by formation of telomere dysfunction-induced foci (TIFs) and end-to-end fusions in ALT-positive cells. In contrast, no telomere phenotype was observed in telomerase-positive cells on FEN1 depletion, suggesting that ongoing telomerase activity protected telomeres. In consonance with this, we found that expression of the catalytic component of telomerase (hTERT) but not an inactive allele rescued telomere dysfunction on FEN1 depletion in ALT cells. Our data suggest that mutations that arise in FEN1 affect telomere stability and genome fidelity by promoting telomere fusions and anaphase-bridge-breakage cycles, which further drive genome instability and thereby contribute to the transformation process.
Asunto(s)
Endonucleasas de ADN Solapado/fisiología , Telómero/genética , Western Blotting , Neoplasias Óseas/genética , Neoplasias Óseas/metabolismo , Neoplasias Óseas/patología , Inestabilidad Genómica , Humanos , Hibridación Fluorescente in Situ , Osteosarcoma/genética , Osteosarcoma/metabolismo , Osteosarcoma/patología , ARN Interferente Pequeño/farmacología , Telomerasa/metabolismo , Telómero/metabolismo , Células Tumorales CultivadasRESUMEN
Glucocorticoid administration to mice results in a rapid loss of bone mineral density due to an imbalance in osteoblast and osteoclast numbers. Whereas excess glucocorticoids reduce both osteoblast and osteoclast precursors, cancellous osteoclast number surprisingly does not decrease as does osteoblast number, presumably due to the ability of glucocorticoids to promote osteoclast life span. Whether glucocorticoids act directly on osteoclasts in vivo to promote their life span and whether this contributes to the rapid loss of bone with glucocorticoid excess remains unknown. To determine the direct effects of glucocorticoids on osteoclasts in vivo, we expressed 11beta-hydroxysteroid dehydrogenase type 2, an enzyme that inactivates glucocorticoids, specifically in the osteoclasts of transgenic mice using the tartrate-resistant acid phosphatase promoter. Bone mass, geometry, and histomorphometry were similar in untreated wild-type and transgenic animals. Glucocorticoid administration for 7 d caused equivalent increases in cancellous osteoblast apoptosis, and equivalent decreases in osteoblasts, osteoid, and bone formation, in wild-type and transgenic mice. In contrast, glucocorticoids stimulated expression of the mRNA for calcitonin receptor, an osteoclast product, in wild-type but not transgenic mice. Consistent with the previous finding that glucocorticoids decrease osteoclast precursors and prolong osteoclast life span, glucocorticoids decreased cancellous osteoclast number in the transgenic mice but not wild-type mice. In accord with this decrease in osteoclast number, the loss of bone density observed in wild-type mice was strikingly prevented in transgenic mice. These results demonstrate for the first time that the early, rapid loss of bone caused by glucocorticoid excess results from direct actions on osteoclasts.
Asunto(s)
Densidad Ósea/efectos de los fármacos , Glucocorticoides/farmacología , Osteoclastos/efectos de los fármacos , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 2/genética , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 2/metabolismo , Animales , Desarrollo Óseo/genética , Huesos/metabolismo , Dexametasona/efectos adversos , Dexametasona/farmacología , Femenino , Glucocorticoides/efectos adversos , Masculino , Ratones , Ratones Transgénicos , Especificidad de Órganos , Osteoclastos/metabolismo , Prednisolona/farmacología , Columna Vertebral/citología , Columna Vertebral/efectos de los fármacos , Columna Vertebral/crecimiento & desarrollo , TransgenesRESUMEN
We show that sex steroids protect the adult murine skeleton through a mechanism that is distinct from that used to preserve the mass and function of reproductive organs. The classical genotropic actions of sex steroid receptors are dispensable for their bone protective effects, but essential for their effects on reproductive tissues. A synthetic ligand (4-estren-3alpha,17beta-diol) that reproduces the nongenotropic effects of sex steroids, without affecting classical transcription, increases bone mass and strength in ovariectomized females above the level of the estrogen-replete state and is at least as effective as dihydrotestosterone in orchidectomized males, without affecting reproductive organs. Such ligands merit investigation as potential therapeutic alternatives to hormone replacement for osteoporosis in both women and men [corrected].
Asunto(s)
Densidad Ósea/efectos de los fármacos , Huesos/efectos de los fármacos , Estrenos/farmacología , Osteoblastos/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Animales , Apoptosis/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Huesos/fisiología , Neoplasias de la Mama/patología , División Celular/efectos de los fármacos , Células Cultivadas , Fuerza Compresiva/efectos de los fármacos , Dihidrotestosterona/farmacología , Estradiol/farmacología , Estrenos/metabolismo , Femenino , Humanos , Masculino , Ratones , Orquiectomía , Tamaño de los Órganos/efectos de los fármacos , Osteoblastos/fisiología , Osteocalcina/sangre , Osteoclastos/fisiología , Osteogénesis/efectos de los fármacos , Osteoporosis/tratamiento farmacológico , Ovariectomía , Pirazoles/farmacología , Receptores de Estrógenos/metabolismo , Vesículas Seminales/efectos de los fármacos , Transcripción Genética/efectos de los fármacos , Células Tumorales Cultivadas , Útero/efectos de los fármacos , Útero/metabolismoRESUMEN
Integrin-mediated adhesion to the extracellular matrix permits efficient growth factor-mediated activation of extracellular signal-regulated kinases (ERKs). Points of regulation have been localized to the level of receptor phosphorylation or to activation of the downstream components, Raf and MEK (mitogen-activated protein kinase/ERK kinase). However, it is also well established that ERK translocation from the cytoplasm to the nucleus is required for G1 phase cell cycle progression. Here we show that phosphorylation of the nuclear ERK substrate, Elk-1 at serine 383, is anchorage dependent in response to growth factor treatment of NIH 3T3 fibroblasts. Furthermore, when we activated ERK in nonadherent cells by expression of active components of the ERK cascade, subsequent phosphorylation of Elk-1 at serine 383 and Elk-1-mediated transactivation were still impaired compared with adherent cells. Elk-1 phosphorylation was dependent on an intact actin cytoskeleton, as discerned by treatment with cytochalasin D (CCD). Finally, expression of active MEK failed to predominantly localize ERK to the nucleus in suspended cells or adherent cells treated with CCD. These data show that integrin-mediated organization of the actin cytoskeleton regulates localization of activated ERK, and in turn the ability of ERK to efficiently phosphorylate nuclear substrates.
Asunto(s)
Transporte Activo de Núcleo Celular/fisiología , Adhesión Celular/fisiología , Núcleo Celular/metabolismo , Proteínas de Unión al ADN , Integrinas/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Factores de Transcripción/metabolismo , Células 3T3 , Animales , Medio de Cultivo Libre de Suero , Ciclina D1/metabolismo , Citocalasina D/farmacología , Citoesqueleto/efectos de los fármacos , Citoesqueleto/metabolismo , Genes Reporteros/genética , Sustancias de Crecimiento/farmacología , Humanos , Immunoblotting , Sistema de Señalización de MAP Quinasas/fisiología , Ratones , Microscopía Fluorescente , Fosforilación/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transfección , Proteína Elk-1 con Dominio etsRESUMEN
Werner syndrome (WS) is marked by early onset of features resembling aging, and is caused by loss of the RecQ family DNA helicase WRN. Precisely how loss of WRN leads to the phenotypes of WS is unknown. Cultured WS fibroblasts shorten their telomeres at an increased rate per population doubling and the premature senescence this loss induces can be bypassed by telomerase. Here we show that WRN co-localizes with telomeric factors in telomerase-independent immortalized human cells, and further that the budding yeast RecQ family helicase Sgs1p influences telomere metabolism in yeast cells lacking telomerase. Telomerase-deficient sgs1 mutants show increased rates of growth arrest in the G2/M phase of the cell cycle as telomeres shorten. In addition, telomerase-deficient sgs1 mutants have a defect in their ability to generate survivors of senescence that amplify telomeric TG1-3 repeats, and SGS1 functions in parallel with the recombination gene RAD51 to generate survivors. Our findings indicate that Sgs1p and WRN function in telomere maintenance, and suggest that telomere defects contribute to the pathogenesis of WS and perhaps other RecQ helicase diseases.
Asunto(s)
ADN Helicasas/metabolismo , Saccharomyces cerevisiae/metabolismo , Telomerasa/metabolismo , Telómero , Proteínas de Unión al ADN/metabolismo , Humanos , Fenotipo , Recombinasa Rad51 , RecQ Helicasas , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiaeRESUMEN
Human immunodeficiency virus type 1 (HIV-1) Vpr is a 96-amino-acid protein that is found associated with the HIV-1 virion. Vpr induces cell cycle arrest at the G(2)/M phase of the cell cycle, and this arrest is followed by apoptosis. We examined the mechanism of Vpr-induced apoptosis and found that HIV-1 Vpr-induced apoptosis requires the activation of a number of cellular cysteinyl aspartate-specific proteases (caspases). We demonstrate that ectopic expression of anti-apoptotic viral proteins, which inhibit caspase activity, and addition of synthetic peptides, which represent caspase cleavage sites, can inhibit Vpr-induced apoptosis. Finally, inhibition of caspase activity and subsequent inhibition of apoptosis results in increased viral expression, suggesting that therapeutic strategies aimed at reducing Vpr-induced apoptosis in vivo require careful consideration.
Asunto(s)
Apoptosis/fisiología , Caspasas/metabolismo , Productos del Gen vpr/fisiología , VIH-1/fisiología , Línea Celular , Activación Enzimática , Humanos , Replicación Viral , Productos del Gen vpr del Virus de la Inmunodeficiencia HumanaRESUMEN
Human cancer cells, unlike their normal counterparts, have shed the molecular restraints to limited cell growth and are immortal. Exactly how cancer cells manage this at the molecular level is beginning to be understood. Human cells must overcome two barriers to cellular proliferation. The first barrier, referred to as senescence, minimally involves the p53 and Rb tumor-suppressor pathways. Inactivation of these pathways results in some extension of lifespan. However, inactivation of these pathways is insufficient for immortalization. As normal cells undergo repeated rounds of DNA replication, their telomeres shorten due to the inability of traditional DNA polymerases to completely replicate the end of the chromosomal DNA. This shortening continues until the cells reach a second proliferative block referred to as crisis, which is characterized by chromosomal instability, end-to-end fusions, and cell death. Stabilization of the telomeric DNA through either telomerase activation or the activation of the alternative mechanism of telomere maintenance (ALT) is essential if the cells are to survive and proliferate indefinitely. Conversely, loss of telomere stabilization by an already-immortalized cell results in loss of immortality and cell death. Together this indicates that telomere maintenance is a critical component of immortality. In this review we attempt to describe our current understanding of the role of telomere maintenance in senescence, crisis, and tumorigenesis.
Asunto(s)
Senescencia Celular/fisiología , Telomerasa/fisiología , Telómero/fisiología , Humanos , Neoplasias/enzimología , Neoplasias/patologíaRESUMEN
Most current anticancer therapies act by inducing tumor cell stasis followed by apoptosis. HIV-1 Vpr effectively induces apoptosis of T cells after arrest of cells at a G(2)/M checkpoint. Here, we investigated whether this property of Vpr could be exploited for use as a potential anticancer agent. As a potentially safer alternative to transfer of genes encoding Vpr, we developed a method to efficiently introduce Vpr protein directly into cells. Vpr packaged into HIV-1 virions lacking a genome induced efficient cell cycle arrest and apoptosis. Introduction of Vpr into tumor cell lines of various tissue origin, including those bearing predisposing mutations in p53, XPA, and hMLH1, induced cell cycle arrest and apoptosis with high efficiency. Significantly, apoptosis mediated by virion-associated Vpr was more effective on rapidly dividing cells compared with slow-growing cells, thus, in concept, providing a potential differential effect between some types of tumor cells and surrounding normal cells. This model system provides a rationale and proof of concept for the development of potential cancer therapeutic agents based on the growth-arresting and apoptotic properties of Vpr.
Asunto(s)
Apoptosis , Productos del Gen vpr/genética , Productos del Gen vpr/metabolismo , Técnicas de Transferencia de Gen , Lentivirus/genética , Lentivirus/metabolismo , Western Blotting , Ciclo Celular/efectos de los fármacos , Ciclo Celular/efectos de la radiación , Línea Celular Transformada , Citometría de Flujo , Fase G2/fisiología , Vectores Genéticos , VIH-1/metabolismo , Células HeLa , Humanos , Cinética , Factores de Tiempo , Productos del Gen vpr del Virus de la Inmunodeficiencia HumanaRESUMEN
Telomerase is a ribonucleoprotein enzyme that maintains the protective structures at the ends of eukaryotic chromosomes, called telomeres. In most human somatic cells, telomerase expression is repressed, and telomeres shorten progressively with each cell division. In contrast, most human tumors express telomerase, resulting in stabilized telomere length. These observations indicate that telomere maintenance is essential to the proliferation of tumor cells. We show here that expression of a mutant catalytic subunit of human telomerase results in complete inhibition of telomerase activity, reduction in telomere length and death of tumor cells. Moreover, expression of this mutant telomerase eliminated tumorigenicity in vivo. These observations demonstrate that disruption of telomere maintenance limits cellular lifespan in human cancer cells, thus validating human telomerase reverse transcriptase as an important target for the development of anti-neoplastic therapies.
Asunto(s)
Mutación , Neoplasias Experimentales/prevención & control , ARN , Telomerasa/antagonistas & inhibidores , Telomerasa/genética , Apoptosis , Neoplasias de la Mama , Dominio Catalítico/genética , División Celular , Neoplasias del Colon , Proteínas de Unión al ADN , Diseño de Fármacos , Femenino , Vectores Genéticos , Humanos , Neoplasias Experimentales/enzimología , Neoplasias Ováricas , Retroviridae/genética , Inhibidores de la Transcriptasa Inversa , Telómero/metabolismo , Células Tumorales CultivadasRESUMEN
Most studies of sexual dimorphism in mammals focus on overall body size. However, relatively little is known about the differences in growth trajectories that produce dimorphism in organ and muscle size. We weighed six organs and four muscles in Rattus norvegicus to determine what heterochronic and allometric scaling differences exist between the sexes. This cross-sectional growth study included 113 males and 109 females with ages ranging from birth to 200 days of age. All muscle and organ weights were ultimately greater in males than in females, because males grew for a longer period of time, had a greater maximum rate of growth, and spent more time near the maximum rate. No ontogenetic scaling differences existed between the sexes in organ weight except for lungs and gonads. During growth, organ weights were negatively allometric to body weight. No scaling differences relative to body weight existed between the sexes for muscles; however, there was variation in the allometric relations among muscles relative to body weight. Sexual dimorphism in muscles and organs appears to be a size difference resulting from differences in the duration and rates of growth.
Asunto(s)
Ratas/anatomía & histología , Ratas/crecimiento & desarrollo , Caracteres Sexuales , Animales , Biometría , Femenino , MasculinoRESUMEN
We have applied Fourier transform infrared (IR) spectroscopic imaging to the investigation of the neuropathologic effects of a genetic lipid storage disease, Niemann-Pick type C (NPC). Tissue sections both from the cerebella of a strain of BALB/c mice that demonstrated morphology and pathology of the human disease and from control animals were used. These samples were analyzed by standard histopathological procedures as well as this new IR imaging approach. The IR absorbance images exhibit contrast based on biochemical variations and allow for the identification of the cellular layers within the tissue samples. Furthermore, these images provide a qualitative description of the localized biochemical differences existing between the diseased and control tissue in the absence of histological staining. Statistical analyses of the IR spectra extracted from individual cell layers of the imaging data sets provide concise quantitative descriptions of these biochemical changes. The results indicate that lipid is depleted specifically in the white matter of the NPC mouse in comparison to the control samples. Minor differences were noted for the granular layers, but no significant differences were observed in the molecular layers of the cerebellar tissue. These changes are consistent with significant demyelination within the cerebellum of the NPC mouse. © 1999 Society of Photo-Optical Instrumentation Engineers.
RESUMEN
Expression of human immunodeficiency virus-type 1 (HIV-1) Vpr after productive infection of T cells induces cell cycle arrest in the G2 phase of the cell cycle. In the absence of de novo expression, HIV-1 Vpr packaged into virions still induced cell cycle arrest. Naturally noninfectious virus or virus rendered defective for infection by reverse transcriptase or protease inhibitors were capable of inducing Vpr-mediated cell cycle arrest. These results suggest a model whereby both infectious and noninfectious virions in vivo, such as those surrounding follicular dendritic cells, participate in immune suppression.
Asunto(s)
Fase G2 , Productos del Gen vpr/fisiología , VIH-1/fisiología , Fármacos Anti-VIH/farmacología , Fase G2/efectos de los fármacos , Genes Reporteros , Genes prv , Inhibidores de la Proteasa del VIH/farmacología , VIH-1/efectos de los fármacos , Células HeLa , Humanos , Indinavir/farmacología , Leucocitos/virología , Nevirapina/farmacología , Inhibidores de la Transcriptasa Inversa/farmacología , Antígenos Thy-1/análisis , Antígenos Thy-1/genética , Virión/fisiología , Zidovudina/farmacología , Productos del Gen vpr del Virus de la Inmunodeficiencia HumanaRESUMEN
The human immunodeficiency virus type 1 (HIV-1) vpr gene is an evolutionarily conserved gene among the primate lentiviruses HIV-1, HIV-2, and simian immunodeficiency viruses. One of the unique functions attributed to the vpr gene product is the arrest of cells in the G2 phase of the cell cycle. Here we demonstrate that Vpr interacts physically with HHR23A, one member of an evolutionarily conserved gene family involved in nucleotide excision repair. Interaction of Vpr with HHR23A was initially identified through a yeast two-hybrid screen and was confirmed by the demonstration of direct binding between bacterially expressed recombinant and transiently expressed or chemically synthesized protein products. Visualization of HHR23A and Vpr by indirect immunofluorescence and confocal microscopy indicates that the two proteins colocalize at or about the nuclear membrane. We also map the Vpr-binding domain in HHR23A to a C-terminal 45-amino-acid region of the protein previously shown to have homology to members of the ubiquitination pathway. Overexpression of HHR23A and a truncated derivative which includes the Vpr-binding domain results in a partial alleviation of the G2 arrest induced by Vpr, suggesting that the interaction between Vpr and HHR23A is critical for cell cycle arrest induced by Vpr. These results provide further support for the hypothesis that Vpr interferes with the normal function of a protein or proteins involved in the DNA repair process and, thus, in the transmission of signals that allow cells to transit from the G2 to the M phase of the cell cycle.
Asunto(s)
Reparación del ADN , Proteínas de Unión al ADN/metabolismo , Productos del Gen vpr/metabolismo , Secuencia de Aminoácidos , Sitios de Unión , Ciclo Celular , Enzimas Reparadoras del ADN , Proteínas de Unión al ADN/genética , Productos del Gen vpr/genética , Glutatión Transferasa , VIH-1/genética , Células HeLa , Humanos , Datos de Secuencia Molecular , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Homología de Secuencia de Aminoácido , Fracciones Subcelulares , Transfección , Productos del Gen vpr del Virus de la Inmunodeficiencia HumanaRESUMEN
This paper describes 2 new species of Acanthobothrium collected in Narcine entemedor from Cuajiniquil, Guanacaste Province, Costa Rica (10 degrees 57'N, 85 degrees 42'W). Acanthobothrium franus n. sp. averages 27 mm long, composed of 110 proglottides, has bothridial hooks 344-469 microns long, and 24-56 testes per proglottis. This new species resembles Acanthobothrium colombianum, Acanthobothrium coquimbensis. Acanthobothrium dujardini, Acanthobothrium lineatum, Acanthobothrium lintoni, and Acanthobothrium paulum. The new species differs from these 6 species by having a relatively shorter cirrus sac length not reaching the middle region of the proglottis. Additionally, A. franus differs from these species by having longer bothridia (627-1,408 microns vs. 299-391 microns for A. colombianum, 312-480 microns for A. coquimbensis, 240-560 microns for A. dujardini, 275-624 microns for A. lineatum, 389-720 microns for A. lintoni, and 300-880 microns for A. paulum), and larger bothridial hooks (344-469 microns vs. 175-193 microns, 120-192 microns, 180-210 microns, 118-216 microns, 108-230 microns, and 104-229 microns, respectively). Acanthobothrium inbiorium n. sp. averages 59 mm long, composed of 198 proglottides, has bothridial hooks 95-120 microns long, and possesses 44-73 testes per proglottis. Among species of Acanthobothrium, the new species resembles Acanthobothrium electricolum, Acanthobothrium dasybati, Acanthobothrium dighaensis, Acanthobothrium icelandicum, Acanthobothrium indicum, Acanthobothrium microcephalum, and Acanthobothrium wedli. The new species closely, resembles A. dasybati, but differs from that species in average strobila length and number of proglottides (58 microns long and 198 proglottides in A. inbiorium vs. 20 and 80 in A. dasybati, respectively). The new species can be distinguished from A. electricolum by having a wider scolex (450-900 microns vs. 189-252 microns), from A. dighaensis by having a narrower scolex (450-900 vs. 1,050-1,429), and from A. indicum by average strobilar length and number of proglottides (58 mm and 198 for A. inbiorium vs. 25 mm and 145 for A. indicum). Finally, A. inbiorium differs from A. icelandicum by having a shorter cirrus sac (122-285 for A. inbiorium vs. 380-410 for A. icelandicum), and A. microcephalum and A. wedli by having longer bothridia (an average of 603 microns vs. 447 microns for A. microcephalum and 350 microns for A. wedli), and fewer testes per proglottis (44-73 vs. 105-115 and 80-100, respectively). Morphological similarities suggest that some components of the eastern Pacific fauna of Acanthobothrium might share historical associations with the Caribbean and the western Pacific/Indian Ocean fauna.
Asunto(s)
Cestodos/clasificación , Infecciones por Cestodos/veterinaria , Enfermedades de los Peces/parasitología , Torpedo/parasitología , Animales , Cestodos/anatomía & histología , Infecciones por Cestodos/parasitología , Costa RicaRESUMEN
The human immunodeficiency virus type 1 (HIV-1) vpr gene encodes a protein which induces arrest of cells in the G2 phase of the cell cycle. Here, we demonstrate that following the arrest of cells in G2, Vpr induces apoptosis in human fibroblasts, T cells, and primary peripheral blood lymphocytes. Analysis of various mutations in the vpr gene revealed that the extent of Vpr-induced G2 arrest correlated with the levels of apoptosis. However, the alleviation of Vpr-induced G2 arrest by treatment with the drug pentoxifylline did not abrogate apoptosis. Together these studies indicate that induction of G2 arrest, but not necessarily continued arrest in G2, was required for Vpr-induced apoptosis to occur. Finally, Vpr-induced G2 arrest has previously been correlated with inactivation of the Cdc2 kinase. Some models of apoptosis have demonstrated a requirement for active Cdc2 kinase for apoptosis to occur. Here we show that accumulation of the hypophosphorylated or active form of the Cdc2 kinase is not required for Vpr-induced apoptosis. These studies indicate that Vpr is capable of inducing apoptosis, and we propose that both the initial arrest of cells and subsequent apoptosis may contribute to CD4 cell depletion in HIV-1 disease.
Asunto(s)
Apoptosis , Productos del Gen vpr/metabolismo , Animales , Proteína Quinasa CDC2/metabolismo , Células COS , Ciclo Celular , Células Cultivadas , Fase G2 , Productos del Gen vpr/genética , VIH-1/fisiología , Células HeLa , Humanos , Linfocitos/citología , Fosforilación , Mutación Puntual , Células Tumorales Cultivadas , Productos del Gen vpr del Virus de la Inmunodeficiencia HumanaRESUMEN
The product of the human immunodeficiency virus type 1 (HIV-1) vpr gene induces cell cycle arrest in the G2 phase of the cell cycle and is characterized by an accumulation of the hyperphosphorylated form of cdc2 kinase. This phenotype is similar to the effect of DNA-damaging agents, which can also cause cells to arrest at G2. We previously reported that Vpr mimicked some of the effects of a DNA alkylating agent known as nitrogen mustard (HN2). Here we extend these earlier observations by further comparing the activation state of cdc2 kinase, the kinetics of G2 arrest, and the ability to reverse the arrest with chemical compounds known as methylxanthines. Infection of cells synchronized in the G1 phase of the cell cycle with a pseudotyped HIV-1 resulted in arrest at G2 within 12 h postinfection, before the first mitosis. Similar to that induced by HN2, Vpr-induced arrest led to a decrease in cdc2 kinase activity. Vpr-mediated G2 arrest was alleviated by methylxanthines at concentrations similar to those needed to reverse the G2 arrest induced by HN2, and cells proceeded apparently normally through at least one complete cell cycle. These results are consistent with the hypothesis that Vpr induces G2 arrest through pathways that are similar to those utilized by DNA-damaging agents.
Asunto(s)
Alquilantes/farmacología , Fase G2/efectos de los fármacos , Genes prv/fisiología , VIH-1/genética , Mecloretamina/farmacología , Proteína Quinasa CDC2/metabolismo , Células HeLa , Humanos , Mitosis , Pentoxifilina/farmacología , Fenotipo , Fase S , Xantinas/farmacologíaRESUMEN
Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia (ATL). We have previously shown that the ATL cell line, RV-ATL, formed tumors when inoculated into severe combined immunodeficient (SCID) mice. In contrast, the HTLV-1 in vitro-transformed cell line, SLB-1, was nontumorigenic in SCID mice. ATL cells contain HTLV-1 proviral DNA sequences but lack detectable viral gene expression, in contrast to HTLV-1 in vitro-transformed cells, which express all viral gene products. We investigated the role of HTLV-1 gene expression in tumorigenesis by superinfecting RV-ATL cells with HTLV-1. The resulting cell line, HT-1RV, expressed HTLV-1. Injection of HT-1RV cells into SCID mice resulted in a reduced tumorigenic phenotype compared to the parental RV-ATL cells. In vitro natural killer (NK) cell cytotoxicity assays revealed that cell lines expressing HTLV-1 gene products, SLB-1 and HT-1RV, were sensitive to NK cell cytolysis. In contrast, nonexpressing RV-ATL cells were resistant to NK cell cytolysis. These studies indicate that lack of viral gene expression allows HTLV-1-infected cells to elude detection by murine NK cells and increases tumorigenicity in SCID mice. Thus the loss of HTLV-1 gene expression in ATL cells may be an important mechanism by which leukemic cells escape immune surveillance in humans.
Asunto(s)
Expresión Génica , Virus Linfotrópico T Tipo 1 Humano/genética , Células Asesinas Naturales/inmunología , Leucemia de Células T/virología , Animales , Transformación Celular Viral , Citotoxicidad Inmunológica , Genes Virales , Virus Linfotrópico T Tipo 1 Humano/inmunología , Humanos , Leucemia de Células T/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones SCID , Trasplante de NeoplasiasRESUMEN
We describe a novel reporter molecule, the murine surface antigen Thy-1, useful for immunoselection and detection of retrovirus-mediated transduction by flow cytometry. A cDNA encoding the murine thy-1 gene was isolated, and cell surface expression of its gene product was demonstrated. The Thy-1 glycoprotein was tested as a cell surface reporter molecule in the context of replication-defective and -competent retroviruses. Cells transduced via murine retroviral vectors carrying the thy-1 and the neomycin phosphotransferase genes express Thy-1 glycoprotein on their surfaces. The Thy-1 marker is potentially useful in gene transfer protocols because selection of transduced cells can be achieved by immunoselection with anti-Thy-1 antibodies shortly after infection with the retroviral vector. In addition, a human immunodeficiency virus type 1 (HIV-1) recombinant expressing Thy-1 is described, which is replication-competent and syncytium-inducing in human peripheral blood mononuclear cells (PBMCs) and immortalized CD4-positive cell lines. Cells infected with this HIV-1 recombinant express Thy-1 on their surfaces and can be detected and purified by fluorescence-activated cell sorting (FACS). Because of these properties, retroviruses expressing this genetic marker can be useful for studies in gene therapy and of the retroviral life-cycle.